title: IL6 genotypes and colon and rectal cancer.
abstract: Inflammation appears to play a key role in the development of colorectal cancer (CRC). In this study we examine factors involved in the regulation of inflammation and risk of CRC. Data from a multi-center case-control study of colon (N = 1579 cases and N = 1977 controls) and rectal (N = 794 cases and N = 1005 controls) cancer were used to evaluate the association between the rs1800795 and rs1800796 IL6 polymorphisms and CRC. We evaluated the joint effects of IL6 single nucleotide polymorphisms and regular use of aspirin/NSAIDs and vitamin D receptor (VDR) genotype. Having a C allele of the rs1800796 IL6 polymorphisms and the GG genotype of the rs1800795 IL6 polymorphisms was associated with a statistically significantly reduced the risk of colon (OR 0.76 95% CI 0.57, 1.00), but not rectal (OR 1.49 95% CI 1.02,2.16) cancer. Both IL6 polymorphisms were associated with significant interaction with current use of aspirin/NSAIDs to alter risk of colon cancer: individuals with a C allele in either polymorphism who were current users of aspirin/NSAIDs had the lowest colon cancer risk. CRC risk also was associated with an interaction between VDR and IL6 genotypes that was modified by current use of aspirin/NSAIDs. This study provides further support for inflammation-related factors in the etiology of CRC. Other studies are needed to explore other genes in this and other inflammation-related pathways.
authors: School of Medicine, University of Utah, Salt Lake City, UT 84108, USA. mslatter@hrc.utah.edu
authors: Martha L
authors: ML
authors: Slattery
authors: Roger K
authors: RK
authors: Wolff
authors: Jennifer S
authors: JS
authors: Herrick
authors: Bette J
authors: BJ
authors: Caan
authors: John D
authors: JD
authors: Potter
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D003110:Colonic Neoplasms / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000235:genetics; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D020641:Polymorphism, Single Nucleotide; D018167:Receptors, Calcitriol / Q000235:genetics; D012004:Rectal Neoplasms / Q000235:genetics*; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; C508600:IL6 protein, human; D015850:Interleukin-6; D018167:Receptors, Calcitriol; D001241:Aspirin
references: Cancer Res. 2003 Jul 1;63(13):3560-6
references: 12839942
references: Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1267-74
references: 11751444
references: Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):744-9
references: 16614118
references: Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):538-45
references: 15066917
references: Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1126-31
references: 16775170
references: J Pharm Sci. 1968 Dec;57(12):2111-6
references: 5708353
references: Mini Rev Med Chem. 2005 Aug;5(8):761-78
references: 16101412
references: J Clin Endocrinol Metab. 1983 Dec;57(6):1308-10
references: 6313738
references: Int J Cancer. 2003 Feb 20;103(5):642-6
references: 12494472
references: Cytokine. 2004 Jul 21-Aug 7;27(2-3):58-65
references: 15242694
references: Mol Endocrinol. 2003 Dec;17(12):2386-92
references: 14500760
references: Am J Epidemiol. 1994 Dec 1;140(11):1020-8
references: 7985650
references: J Clin Endocrinol Metab. 2004 Apr;89(4):1885-90
references: 15070960
references: Cancer Res. 1997 Mar 15;57(6):1098-102
references: 9067278
references: Cancer. 1964 May;17:657-65
references: 14159812
references: Mol Cell Endocrinol. 2001 May 25;177(1-2):145-59
references: 11377830
references: Arch Intern Med. 1999 Jan 25;159(2):161-6
references: 9927099
references: Clin Chem. 2004 Nov;50(11):2136-40
references: 15364891
references: Diabetes. 2002 Jul;51(7):2294-300
references: 12086963
references: Carcinogenesis. 2003 Jun;24(6):1091-5
references: 12807755
references: Cancer Causes Control. 2001 May;12(4):359-64
references: 11456232
references: Cancer Causes Control. 2006 Apr;17(3):239-49
references: 16489531
references: Crit Care Med. 2005 Jan;33(1):89-97; discussion 242-3
references: 15644653
references: Gut. 1992 Dec;33(12):1660-3
references: 1336758
references: N Engl J Med. 1971 Jul 1;285(1):17-21
references: 5089367
references: Adv Prostaglandin Thromboxane Res. 1980;8:1287-9
references: 6769309
references: FASEB J. 2003 Mar;17(3):509-11
references: 12551842
references: Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):747-55
references: 17416766
references: Int J Oncol. 1999 Sep;15(3):589-94
references: 10427145
references: J Am Diet Assoc. 1994 Jul;94(7):761-6
references: 8021418
references: Int J Cancer. 2002 Mar 1;98(1):84-91
references: 11857390
references: Epidemiol Rev. 1993;15(2):499-545
references: 8174669
references: Eur J Cancer. 2006 Apr;42(6):704-7
references: 16513341
references: Diabetes. 1966 Oct;15(10):730-3
references: 5924835
references: Diabetes. 1960 Sep-Oct;9:416-8
references: 13707654
references: Science. 2001 Aug 31;293(5535):1673-7
references: 11533494
references: Cancer Causes Control. 2002 Nov;13(9):813-23
references: 12462546
references: Cancer Lett. 2006 Jun 18;237(2):199-206
references: 16019132
references: Diabetes Care. 1982 Jan-Feb;5(1):64-71
references: 6754304
references: JAMA. 2004 Feb 4;291(5):585-90
references: 14762037
references: Ann Intern Med. 2005 Mar 15;142(6):425-32
references: 15767620
references: Cancer Res. 1997 Jan 1;57(1):75-80
references: 8988044
references: J Epidemiol. 2005 Jun;15 Suppl 2:S185-9
references: 16127232
references: Cancer Causes Control. 2001 Sep;12(7):607-14
references: 11552708
references: Arch Biochem Biophys. 2002 Jun 15;402(2):249-54
references: 12051670
references: Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):277-300
references: 12887108
references: Cancer Res. 1992 Oct 15;52(20):5575-89
references: 1394181
references: J Clin Invest. 2002 May;109(10):1321-6
references: 12021247
references: World J Gastroenterol. 2006 Aug 21;12(31):5037-43
references: 16937502
references: J Clin Invest. 1998 Oct 1;102(7):1369-76
references: 9769329
references: Cancer Res. 2006 Feb 15;66(4):2483-7
references: 16489056
references: Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):869-74
references: 11489753
references: J Clin Endocrinol Metab. 2003 Jan;88(1):255-9
references: 12519862
references: J Cell Biochem. 2003 Aug 1;89(5):922-32
references: 12874827
references: Br J Cancer. 1999 Sep;81(1):62-8
references: 10487613
references: Mol Endocrinol. 2000 Mar;14(3):401-20
references: 10707958